UC research points to potential new treatment for pancreatic cancer
June 8, 2020
Researchers have discovered a new potential targeted treatment for pancreatic cancer. The next steps are clinical trials.
June 8, 2020
Researchers have discovered a new potential targeted treatment for pancreatic cancer. The next steps are clinical trials.
June 5, 2020
Hundreds gathered on the UC Academic Health Center campus June 5 to silently protest the death of George Floyd and many others at the hands of police.
June 2, 2020
Cincinnati media outlets provide details about a UC study that discusses how COVID-19 impacts the brain.
June 16, 2020
Richard Becker, MD, director of the UC Heart, Lung and Vascular Institute, was interviewed for a story on long-term care of patients after COVID-19. Becker acknowledged that while some hospitals at the forefront of COVID-19 epicenters may be leading the way, others including academic health centers aren’t far behind in their plans.
June 15, 2020
Tamara Ward, a specialist in oncology nutrition at the University of Cincinnati Cancer Center, discusses nutrition and the immune system in this USA Today article.
June 15, 2020
UPI covers new research from UC that details a potential new pancreatic cancer therapy.
June 15, 2020
Dr. Carl Fichtenbaum of the UC College of Medicine Division of Infectious Diseases was interviewed by Yahoo for an article on whether it's safe to public swimming pools this spring and summer.
June 16, 2020
The UC Health Transplant Program and the University of Cincinnati College of Medicine will host a transplant research virtual symposium beginning 9 a.m. Friday, June 26, designed to connect physicians and medical professionals with some of the latest innovations in organ transplantation.
June 17, 2020
Researchers at the University of Cincinnati and UC Health will host a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2. UC is one of approximately 90 sites across the United States selected for the study, which will administer the vaccine candidate mRNA-1273 to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19.
June 18, 2020
MSN and other media outlets covered the news about researchers at the University of Cincinnati and UC Health hosting a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2.